.With a triad of biotechs attacking the Nasdaq on Friday, it was quick and easy to miss a smaller-sc...
.Invulnerable checkpoint preventions are the superheroes of cancer treatment. Drugs like Bristol Mye...
.Welcome to recently's Chutes & Ladders, our summary of substantial management hirings, firings a...
.Regeneron is actually back along with long-lasting consequence for its own LAG-3 inhibitor and PD-1...
.AstraZeneca has discussed a very early look at the functionality of its own in-house antibody-drug ...
.After announcing a phase 3 launch based on good midstage outcomes, iTeos and GSK are ultimately dis...
.The FDA must be extra available and also collaborative to unleash a surge in approvals of rare cond...
.It is actually an unusually busy Friday for biotech IPOs, along with Zenas BioPharma, MBX and Bicar...
.Atea Pharmaceuticals' antiviral has actually fallen short one more COVID-19 test, but the biotech s...
.Neurocrine Biosciences' schizophrenia program pivot has neglected. The biotech was not able to repr...